Results
|
|
4321.
|
|
|
|
4322.
|
|
|
|
4323.
|
Risk Factors for Malignant Transformation of Low-Grade Glioma. [electronic resource] by
- Murphy, Erin S
- Leyrer, Charles M
- Parsons, Michael
- Suh, John H
- Chao, Samuel T
- Yu, Jennifer S
- Kotecha, Rupesh
- Jia, Xuefei
- Peereboom, David M
- Prayson, Richard A
- Stevens, Glen H J
- Barnett, Gene H
- Vogelbaum, Michael A
- Ahluwalia, Manmeet S
Producer: 20190220
In:
International journal of radiation oncology, biology, physics vol. 100
Availability: No items available.
|
|
|
4324.
|
|
|
|
4325.
|
|
|
|
4326.
|
|
|
|
4327.
|
|
|
|
4328.
|
|
|
|
4329.
|
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients. [electronic resource] by
- Schaich, M
- Kestel, L
- Pfirrmann, M
- Robel, K
- Illmer, T
- Kramer, M
- Dill, C
- Ehninger, G
- Schackert, G
- Krex, D
Producer: 20090319
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
|
4330.
|
|
|
|
4331.
|
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. [electronic resource] by
- Peereboom, David M
- Shepard, Dale R
- Ahluwalia, Manmeet S
- Brewer, Cathy J
- Agarwal, Neeraj
- Stevens, Glen H J
- Suh, John H
- Toms, Steven A
- Vogelbaum, Michael A
- Weil, Robert J
- Elson, Paul
- Barnett, Gene H
Producer: 20100908
In:
Journal of neuro-oncology vol. 98
Availability: No items available.
|
|
|
4332.
|
|
|
|
4333.
|
MGMT methylation: a marker of response to temozolomide in low-grade gliomas. [electronic resource] by
- Everhard, Sibille
- Kaloshi, Gentian
- Crinière, Emmanuelle
- Benouaich-Amiel, Alexandra
- Lejeune, Julie
- Marie, Yannick
- Sanson, Marc
- Kujas, Michèle
- Mokhtari, Karima
- Hoang-Xuan, Khê
- Delattre, Jean-Yves
- Thillet, Joëlle
Producer: 20070226
In:
Annals of neurology vol. 60
Availability: No items available.
|
|
|
4334.
|
Phase II study of extended-dose temozolomide in patients with melanoma. [electronic resource] by
- Rietschel, Petra
- Wolchok, Jedd D
- Krown, Susan
- Gerst, Scott
- Jungbluth, Achim A
- Busam, Klaus
- Smith, Katherine
- Orlow, Irene
- Panageas, Katherine
- Chapman, Paul B
Producer: 20080527
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26
Availability: No items available.
|
|
|
4335.
|
MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis. [electronic resource] by
- Sato, Atsushi
- Sunayama, Jun
- Matsuda, Ken-ichiro
- Seino, Shizuka
- Suzuki, Kaori
- Watanabe, Eriko
- Tachibana, Ken
- Tomiyama, Arata
- Kayama, Takamasa
- Kitanaka, Chifumi
Producer: 20120312
In:
Stem cells (Dayton, Ohio) vol. 29
Availability: No items available.
|
|
|
4336.
|
|
|
|
4337.
|
A phase I study of bortezomib and temozolomide in patients with advanced solid tumors. [electronic resource] by
- Portnow, J
- Frankel, P
- Koehler, S
- Twardowski, P
- Shibata, S
- Martel, C
- Morgan, R
- Cristea, M
- Chow, W
- Lim, D
- Chung, V
- Reckamp, K
- Leong, L
- Synold, T W
Producer: 20120320
In:
Cancer chemotherapy and pharmacology vol. 69
Availability: No items available.
|
|
|
4338.
|
|
|
|
4339.
|
Targeting protein-trafficking pathways alters melanoma treatment sensitivity. [electronic resource] by
- Huang, Zhi-ming
- Chinen, Milka
- Chang, Philip J
- Xie, Tong
- Zhong, Lily
- Demetriou, Stephanie
- Patel, Mira P
- Scherzer, Rebecca
- Sviderskaya, Elena V
- Bennett, Dorothy C
- Millhauser, Glenn L
- Oh, Dennis H
- Cleaver, James E
- Wei, Maria L
Producer: 20120312
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 109
Availability: No items available.
|
|
|
4340.
|
|